TAT-Modified ω-Conotoxin MVIIA for Crossing the Blood-Brain Barrier

As the first in a new class of non-opioid drugs, ω-Conotoxin MVIIA was approved for the management of severe chronic pains in patients who are unresponsive to opioid therapy. Unfortunately, clinical application of MVIIA is severely limited due to its poor ability to penetrate the blood-brain barrier...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mar Drugs
Main Authors: Yu, Shuo, Li, Yumeng, Chen, Jinqin, Zhang, Yue, Tao, Xinling, Dai, Qiuyun, Wang, Yutian, Li, Shupeng, Dong, Mingxin
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562543/
https://ncbi.nlm.nih.gov/pubmed/31083641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md17050286
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker